• Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
  • Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
  • Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
  • Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
  • Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
  • Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment

Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment

Certification: CE
Disinfection: Disinfection
Color: Transparent
Application: Use Areas Face, Body
Material: Sodium Hyaluronate
Transport Package: Box
Diamond Member Since 2020

Suppliers with verified business licenses

Rating: 5.0/5
Trading Company

Basic Info.

Model NO.
Ozempics
Specification
1.5ml*0.25mg / 3ml*1mg
Trademark
Ozempics
Origin
Korea
Production Capacity
10000

Product Description

Product Description

Lose Weight Removal Fat Ozempics Saxendas Semaglutide Injection 1.5ml  3ml 

Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment

ozempics 1ml  3ml


Product Description

A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received metformin and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease.

Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment

 
Based on the natural human GLP-1 molecule, the eighth (alanine → alpha-aminobutyric acid) and the 34th amino acid (lysine → arginine) were substituted, while lysine at the 26th was linked to the C18 adipose acid side chain by spacer group. After the modification of human GLP-1 molecule, Smeiglutide can resist the degradation of dipeptidyl peptidase 4 (DPP-4), bind closely to albumin, significantly prolong the half-life in vivo, achieve once a week administration, and retain up to 94% of GLP-1 amino acid sequence homology, with good safety.

In December 2017, the US Food and Drug Administration (FDA) approved Smegalutide injection for the control of blood sugar in adults with type 2 diabetes.

In January 2020, it was approved by the FDA to reduce the risk of major cardiovascular adverse events in adults with type 2 diabetes with cardiovascular disease.

On December 4, 2020, Novo Nordisk submitted to the FDA a marketing application for weight loss with Smeiglutide 2.4mg subcutaneously injected once a week.

In April 2021, it was approved by the State Food and Drug Administration (NMPA) for the treatment of adult type 2 diabetes mellitus and reducing the risk of cardiovascular adverse events in patients with T2DM combined with cardiovascular disease.

On December 3, 2021, it was included in the "National Basic Medical Insurance, industrial injury Insurance and maternity Insurance Drug Catalog (2021)".

Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment

 

 

character
This product is colorless or almost colorless clear isotonic liquid; pH=7.4.

Fold edit this paragraph for indications
This product is suitable for glycemic control in adults with type 2 diabetes: adults with type 2 diabetes who are treated with metformin and/or sulfonylurea on the basis of diet control and exercise and still have poor glycemic control.

It is indicated to reduce the risk of major cardiovascular adverse events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus with cardiovascular disease.

Fold and edit this section specification
The specifications of this product are:

1.34mg/ml, 1.5ml (Pre-filled Injection pen)

1.34mg/ml, 3ml (Pre-filled Injection pen)

Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment


 
 
Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
 
Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
 
Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment
 



Products you are interested in

Korea Saxendas Pen Ozempics Online Liraglutide Injection for Weight Loss Overweight Individuals Lose Weight Effectively Obesity Treatment

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now